Active-ingredient Dossier
Lacosamide
Active-ingredient Dossier for Lacosamide (anticonvulsant agent). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: LACOSAMIDE
- Brand: VIMCOSA
- Brand: VIMPAT
- Brand: LACOMED
- Brand: LACOSACOR
- Brand: LACOSAM
- Therapeutic area: Neurology
What is
Lacosamide Lacosamide is an anticonvulsant agent.
Australian brands containing
Lacosamide — LACOSAMIDE — VIMCOSA — VIMPAT — LACOMED — LACOSACOR — LACOSAM — LACOSAMIDE Lupin — LACOSAMIDE SANDOZ — LACOVIM — APO-LACOSAMIDE
Therapeutic areas
Lacosamide is registered in neurology, with 17 brands containing this ingredient on the ARTG.
Sponsor landscape
Lacosamide is marketed by 10 sponsors, including Medsurge Pharma, Pharmacor, Accord Healthcare, Arrotex Pharmaceuticals, Alembic Pharmaceuticals, and Interpharma.
PBS and regulatory activity
Three brands containing lacosamide have PBS-listed items, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome was recorded on 1 March 2021 and the latest AusPAR on 24 July 2018.